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Summary
Background Long-chain n-3 polyunsaturated fatty acids (PUFAs) have immune regulating
and anti-inﬂammatory effects. However, their role in allergic disease is unclear. Allergic
diseases are immunologically heterogeneous, and we hypothesized that n-3 fatty acid
composition in serum and breast milk may vary according to clinical manifestations. Further,
animal studies have shown reduction of serum-PUFA levels during allergic inﬂammation.
Objective To investigate fatty acid composition in breast milk and serum from women with
different atopic disease manifestations. Secondly, to determine whether low PUFA levels
reﬂected insufﬁcient intakes.
Methods Fatty acids were analysed in breast milk and serum of women with atopic eczema
and respiratory allergy (n=16), only respiratory allergy (n=7), as well as healthy women
(n=22). Dietary intake of foods expected to affect long-chain n-3 PUFA levels were estimated
by food-frequency questionnaire. The fatty acid pattern was related to diagnostic group and
intake of relevant food items using a multivariate pattern recognition method (partial least
squares projections to latent structures and discriminant analysis).
Results Women with a combination of eczema and respiratory allergy had lower breast milk
levels of several PUFAs (arachidonic acid, eicosapentaenoic acid, EPA, docosahexaenoic acid,
DHA, and docosapentaenoic acid, DPA), and a lower ratio of long-chain n-3 PUFAs/n-6
PUFAs. Their PUFA levels differed not only from that of healthy women, but also from that of
women with only respiratory allergy. The latter had a fatty acid pattern similar to that of
healthy women. Despite low EPA, DHA and DPA levels women with eczema and respiratory
allergy consumed no less ﬁsh than did healthy women.
Conclusion & Clinical Relevance Our data suggest that reduced levels of long-chain n-3 fatty
acids in serum and breast milk characterize women with extensive allergic disease including
eczema, and are not related to low ﬁsh intake. Consumption of PUFAs during the allergic
process may explain these ﬁndings.
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Allergies have increased dramatically in Western societies
during the last century [1]. Factors associated with the
Western life-style, such as reduced exposure to microbes,
have been proposed to explain this epidemic [2]. In
addition, both epidemiological and experimental evidence
suggest that dietary habits may inﬂuence the risk of
developing allergy [3]. Dunder et al. [4] proposed in 2001
that increased intake of unsaturated fatty acids could
increase the risk of allergy development as the diet of
children with atopic dermatitis contained less butter and
more margarine and, hence, was characterized by a higher
ratio of polyunsaturated/saturated fatty acids than of
healthy controls. Similarly, von Mutius et al. [5] reported
that consumption of less butter and more margarine could
explain the rise in atopy with Westernization. Margarine
contains high concentrations of the n-6 polyunsaturated
fatty acid (PUFA) linoleic acid (LA) compared with butter,
which mainly contains saturated fat [5].
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series, are found in ﬁsh. These include eicosapentaenoic
acid (EPA), docosahexaenoic acid (DHA) and docosapen-
taenoic acid (DPA). Consumption of n-3 PUFAs may
modulate various immunologic and inﬂammatory path-
ways [6]. Recent publications have reported lower inci-
dence of eczema in children whose diet has included ﬁsh
[7–9] and whose mothers had high ﬁsh intake during
pregnancy [10, 11]. Consumption of ﬁsh has been
associated with reduced allergic symptoms also in adults
[12, 13].
It is generally considered that dietary intake of ﬁsh n-3
fatty acids is reﬂected in breast milk and serum. But EPA,
DPA and DHA can also be synthesized by humans from
a-linolenic acid, a shorter type of n-3 PUFA found in
green leafy vegetables and vegetable oils. However, EPA
and DPA are synthesized at low efﬁciency and DHA seems
to increase very little with a-linolenic acid supplementa-
tion [14]. Intervention with long-chain n-3 PUFAs have
yielded conﬂicting results, some studies reporting reduced
allergic symptoms [15, 16], others no effect [17]. Accord-
ingly, high n-3 PUFA content of mother’s milk has been
associated with lower [18, 19] or higher [20] risk of allergy
development in the infant. Still another study shows no
relation to allergy but reduction of non-atopic eczema
[21]. Long-chain n-3 PUFA content in breast milk from
atopic and non-atopic women have also been compared in
several studies, with conﬂicting results. Some showed no
fatty acid differences [20, 22, 23], some reported lower n-3
fatty acid levels [24, 25] and one [26] higher DPA levels in
milk from atopic compared with healthy mothers. Studies
regarding PUFA content in breast milk have usually
included women with different atopic manifestations,
such as asthma, hayfever and/or eczema. One reason for
the divergent results regarding n-3 PUFA pattern in
atopy may be that these mediators have different effects
on different allergic manifestations, e.g. asthma vs. atopic
eczema.
A further complication is that low serum PUFA levels
are associated with active allergy, this may either indicate
a protective effect of n-3 fatty acids, or enhanced con-
sumption of these fatty acids during inﬂammation. Evi-
dence supporting an enhanced consumption of long-
chain n-3 PUFAs includes Dunder’s et al. [4] study in
which children with atopic eczema were found to have
lower serum levels of EPA and DHA than non-atopic
children, despite similar levels of ﬁsh consumption.
Furthermore, we have recently demonstrated a pro-
nounced consumption of long-chain PUFAs, including
EPA and DHA during the challenge phase of an experi-
mental airway allergy model [27].
The aim of this study was to investigate differences in
fatty acid composition in breast milk and serum from
healthy women and women suffering from atopic eczema
and/or respiratory allergy. The second aim was to investi-
gate whether differences in PUFA levels correlated with
differences in dietary intake.
Methods
Subjects
The studypopulationcomprised 45 womenwho gave birth
from September 2005 to September 2007, 18 of whom
were from the city of G¨ oteborg in southwest Sweden and
27 living in a rural area around 100km from G¨ oteborg.
The women were recruited at the respective antenatal
clinics and ﬁlled out a questionnaire probing for doctor’s
diagnosed allergic disease. Women with a clear history of
asthma, allergic rhinitis (AR) and/or atopic eczema were
included, as well as a number of healthy women without
any allergic symptoms. To conﬁrm the atopic/healthy
state, a blood sample was drawn and analysed for total
IgE and speciﬁc IgE antibodies to a panel of common
inhalant allergens, namely: dog, cat, horse, birch, timothy,
mugwort, Dermatophagoides pteronyssinus, D. farinae
and Cladosporium (Phadiatop, Pharmacia, Uppsala, Swe-
den). The analyses were performed at the Allergy Labora-
tory, Sahlgrenska University Hospital, G¨ oteborg, Sweden.
The groups were of similar age (median age 32, 32 and
30 years for healthy, eczema1respiratory allergy and
respiratory allergy only, respectively). Only two women
reported smoking (one healthy, one eczema) and two
women in the eczema group reported intake of omega-3
supplements (one ﬁsh oil and one ﬂaxseed oil). In the
eczema group 13 of 16 women took allergy medication
(eight antihistamines, ﬁve b2-agonists, six local cortisone,
one sodium cromoglicate and one combined cortico-
steroids and b2-agonists). In the respiratory group, four
of seven women took medication (four antihistamines,
one b2-agonists, one systemic cortisone, one local corti-
sone and one sodium cromoglicate).
The participating women were asked to complete a food-
frequency questionnaire based on the validated Northern
Sweden FFQ [28], including selected foods expected to
affect long-chain n-3 and n-6 fatty acid levels in breast
milk and serum, i.e. marine foods (fat ﬁsh, lean ﬁsh and
shellﬁsh), butter, margarine and vegetable oils. The parti-
cipants were asked to mark how often they consumed
different food products, and the frequencies were then
converted to g/wk. Written informed consent was obtained
and the study was approvedby the regional Ethics Commit-
tee, University of Gothenburg, permission number 363-05.
Collection of breast milk and serum samples
Breast milk samples were collected 1 month post-partum,
during the second mealofthe day. Five to 10mLof milk was
expressed manually into sterile plastic tubes and frozen
immediately at –201C at home. Milk samples were later
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analysed. Venous blood, 5–10mL, was drawn from the
women and after centrifugation, serum was immediately
frozen in aliquots and stored at –801C until analysed.
Analysis of fatty acids in breast milk
Fatty acids in the total lipid fraction of breast milk samples
were analysed by gas chromatography after conversion to
methyl esters [29]. Milk samples (100mL) were thawed
slowly in cold water, vortexed and mixed with 2mL
toluene, 2mL acetyl chloride (10%) dissolved in methanol,
and 50mL internal standard (fatty acid 21:0, 0.5mg/mL).
After incubation in a 701C water bath for 2h, methyl ester
were extractedwithpetroleum ether, and after evaporation,
dissolved in isooctane and separated by gas chromatogra-
phy (Hewlett Packard 5890, Waldbronn, Germany) on a HP
Ultra 1 (50m0.32mm0.52mm DF) column (J&W Scien-
tiﬁc, Folsom, CA, USA). Detection was carried out by ﬂame
ionization and the Borwin software (JMBS Developments,
Le Fontanil, France) was used for evaluation. The samples
were analysed regarding the 12 unsaturated fatty acids
shown in Fig. 1 with a length of 18–22 carbon atoms, as
well as 10 other fatty acids; all shown in Table 1. The n-3
fatty acids EPA (20:5 n-3), DPA (22:5 n-3) and DHA (22:6
n-3) are characteristically present in ﬁsh, but can also be
formed from a-linolenic acid (LNA, 18:3 n-3), Fig. 1. Long-
chain n-6 fatty acids can be formed from dietary LA (18:2
n-6) by elongation (Fig. 1).
Analysis of serum fatty acids
Serum phospholipid composition was determined by ex-
tracting fat from serum with chloroform and methanol
[30]. Serum (500mL) was mixed with 4mL of chloroform:
methanol (1:2), 2mL 0.5% NaCl-solution and 50mL of the
internal standard, fatty acid 17:0. The chloroform phase
was collected, and after evaporation, the fat was dissolved
in 200mL chloroform. Phospholipids were obtained by
separation on aminopropyl solid phase extraction col-
umns (Isolute NH2, 6mL, 500mg, IST, Mid Glamorgon,
UK) [31]. After evaporation, phospholipids were redis-
solved in 1mL toluene, converted to methyl esters and
analysed as described above.
Total content of protein and lactose in breast milk
Total protein concentrations in milk samples were deter-
mined spectrophotometrically according to Lowry [32] as
modiﬁed by Markwell [33]. The lactose content was deter-
mined by high-performance liquid chromatography [34].
Statistical analysis
Principal component analysis (PCA) and projections to
latent structures by means of partial least square (PLS)
are two multivariate data analysis techniques particu-
larly suitable when having large data sets consisting of
numerous variables. In PCA, the original set of correlated
variables are combined into a small number of new
variables, termed ‘latent variables’ or ‘principal compo-
nents’, each of which accounts for as much of the variance
of the original data as possible and which are also
uncorrelated to one another [35]. In PLS, ‘latent variables’
or ‘score vectors’ that covaries maximally with a selected
Y variable, for example a certain clinical condition, is
searched, which makes PLS a regression extension of PCA
[36]. PLS with discriminant analysis (PLS-DA) separates
observations into predetermined classes of observations
(e.g. different clinical conditions) on the basis of all
variables [35]. The variables that contribute to the separa-
tion of the classes can then be identiﬁed. These methods
permit an evaluation of differences in variables without
the risk of problems with mass signiﬁcance and need for
normal distribution of data or strict independence among
variables as in conventional statistics. We used PLS-DA to
ﬁnd a model able to separate the three clinical classes: (1)
LA 18:2 n-6 LNA 18:3 n-3
Linoleic acid α-Linolenic acid
Δ6-Desaturase
18:3 n-6 18:4 n-3
Elongation
20:3 n-6 20:4 n-3
Δ5-Desaturase
AA 20:4 n-6 EPA 20:5 n-3
Arachidonic acid Eicosapentaenoic acid
Elongation
22:4 n-6 DPA 22:5 n-3
Docosapentaenoic acid
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24:4 n-6 24:5 n-3
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Fig. 1. The metabolic pathway for polyunsaturated fatty acids linoleic
and a-linolenic acids.
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isolated respiratory allergy, respectively. The separation is
based on all variables analysed, i.e. breast milk levels of
fatty acids, lactose and protein, serum phospholipids fatty
acids and dietary variables. Multivariate statistical ana-
lyses were performed using Simca-P112.0 (Umetrics,
Ume˚ a, Sweden).
The variables identiﬁed by PLS-DA as most important
for class separation were investigated by univariate sta-
tistical analyses comparing the three groups of women.
Univariate analyses were performed with SPSS 15.0 (SPSS
Inc., Chicago, IL, USA). Mann–Whitney U-test was used
to determine differences between the subject groups
(P40.05 was considered signiﬁcant) regarding fatty acids,
since these were not normally distributed. Student’s t-test
was used to analyse group differences regarding protein
and lactose content in milk and dietary intake. Correla-
tions were analysed by Spearman’s rank correlation.
Results
Milk and serum were obtained from 22 non-allergic and
23 allergic women. Among the allergic women, 15 had
both respiratory symptoms (asthma and/or AR) and ecze-
ma, while seven had respiratory symptoms only and one
had only eczema. The women were divided into three
groups: (1) eczema and respiratory allergy (n=16). This
group included those with both eczema and respiratory
symptoms as well as the single individual with eczema
only. They all tested positive for speciﬁc IgE (4160IU/
mL) against at least one allergen, and ﬁve of 16 also had
raised levels of total IgE (4100kU/L). (2) Isolated respira-
tory allergy (n=7), deﬁned as asthma and/or allergic
rhinoconjuctivitis, but no eczema. All had speciﬁc IgE
against at least one allergen and three of seven also
had elevated levels of total IgE. (3) Non-allergic (n=22)
deﬁned as no symptoms and negative tests for speciﬁc IgE
Table 1. Fatty acid content in the total lipid fraction of breast milk (1 month)
Fatty acids (% of total fatty acids)
P-value Healthy (n=22)
Eczema1respiratory
allergy (n=16)
Only respiratory
allergy (n=7)
18:0 7.30.26 7.00.55 6.90.40 NS
18:1 n-9 370.57 342.2 390.58 0.03
18:1 n-7 2.20.08 1.90.25 2.20.08 NS
18:2 n-6 (LA) 100.42 9.60.87 100.55 NS
18:3 n-6 0.150.01 0.230.07 0.170.04 NS
18:3 n-3 (LNA) 1.40.07 1.30.15 1.30.10 NS
18:4 n-3 0.050.01 0.110.03 0.060.02 NS
20:4 n-6 (AA) 0.410.02 0.370.02 0.450.02 0.01
20:5 n-3 (EPA) 0.140.01,a 0.100.01,a,b 0.150.02,b 0.05
a, 0.02
b
20:3 n-6 0.400.02 0.410.02 0.380.03 NS
20:4 n-3 0.220.01 0.200.01 0.180.02 NS
20:2 n-6 0.260.01 0.290.02 0.260.01 NS
20:1 n-7 0.0550.003 0.0620.004 0.0510.001 NS
20:0 0.200.01 0.220.01 0.200.01 NS
22:5 n-6 0.0300.002 0.0250.002 0.0290.003 NS
22:6 n-3 (DHA) 0.330.04 0.240.03 0.340.04 0.04
22:4 n-6 0.0720.004 0.0710.004 0.0690.003 NS
22:5 n-3 (DPA) 0.190.01
a 0.160.01
a,b 0.190.01
b 0.05
a (P=0.06
b)
22:2 n-6 0.070.03 0.040.003 0.040.01 NS
22:1 n-9 0.110.01 0.0980.004 0.0910.01 NS
22:3 n-3 0.0070.001 0.0060.001 0.0030.002 NS
22:0 0.090.004 0.140.04 0.0810.01 NS
LA/LNA 7.60.39 7.70.52 8.40.59 NS
AA/EPA 3.30.21
a 3.80.20
a,b 3.20.34
b NS (P=0.06
a, P=0.07
b)
AA/DHA 1.60.15 1.70.13 1.41.2 NS
AA/DPA 2.30.11 2.50.12 2.40.18 NS
n-6 LCP/n-3 LCP 1.50.07,a 1.80.09,a,b 1.40.10,b 0.03
a, 0.02
b
tot n-6/tot n-3 4.90.49
a,b 6.10.44
a 6.50.36
b NS (P=0.09
a, P=0.07
b)
These groups are signiﬁcantly different, P40.05.
a,bMarking of group-differences with P-value as indicated.
ns, no signiﬁcant group differences; LCP, long chain polyunsaturated fatty acids, the sum of all fatty acids analysed, except the 18 carbon long fatty
acids; tot, total fatty acids, the sum of 14–22 carbon atoms long fatty acids.
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serum IgE level below 100kU/L. The women in the eczema
and respiratory allergy group reported allergic reactions
against the following: grass (n=2), grass and furred pets
(n=2), grass and foods (n=2), furred pets and foods
(n=3), foods and birch pollen (n=1), furred pets, foods
and birch pollen (n=1), grass, foods and birch pollen
(n=1), grass, foods, birch pollen and mugwort (n=1),
grass, furred pets, foods, birch pollen and mugwort (n=1)
and furred pets, foods, birch pollen and mites (n=1).In
the isolated respiratory group, women reported allergic
reaction against the following: grass and mugwort (n=1),
foods and birch pollen (n=1), furred pets (n=1) and birch
pollen (n=4). Thus, women with eczema and respiratory
allergy reported responses to 2.4 allergen groups com-
pared with 1.3 in the ‘respiratory only’ group.
Multivariate statistical analysis by PLS-DA
Fatty acids, lactose and proteins were analysed in breast
milk and fatty acids in serum. Intake of fat containing
food items were registered as estimated intake per week (g/
wk). Altogether 41 variables were used to obtain separa-
tion between the three clinical groups: healthy, eczema
plus respiratory allergy or isolated respiratory allergy. In
the PLS-DA score plot (Fig. 2a), each symbol represents
one individual and the position of the symbol is achieved
through a combination of this individual’s values on all
variables. Women with both eczema and respiratory
allergy were clearly separated from both women with
only respiratory allergy and healthy women, while the
latter two groups showed almost complete overlap. The
PLS-DA loading plot (Fig. 2b) shows to what extent the
different variables contribute to the class separation. The
loading plot and the score plot correspond; hence vari-
ables located in the lower left corner of the loading plot
have higher values in subjects located in the lower left
corner of the score plot, i.e. those belonging to the eczema
and respiratory allergy group, whereas variables in the
upper right corner tend to attain higher values in healthy
women and women with respiratory symptoms only. High
breast milk levels of n-3 fatty acids of the types found in
ﬁsh, i.e. EPA, DPA and DHA, as well as the n-6 fatty acid
arachidonic acid (AA) were all clustered in the ‘healthy’
corner together with high serum levels of EPA (Fig. 2b).
Conversely, 18:4 n-3, 20:1 n-7 and 20:2 n-6 as well as high
ratio of n-6 to n-3 PUFAs clustered in the lower left corner,
close to the ‘eczema and respiratory allergy’ class position.
Interestingly, high dietary intake of fatty ﬁsh appeared close
to the ‘respiratory allergy only’ group, but high consump-
tion of lean ﬁsh and total intake of ﬁsh and shellﬁsh were
connected to the ‘eczema and respiratory allergy’ class.
Butter consumption appeared close to the healthy state.
The Variables of Importance in the Projection-plot
(VIP-plot), Fig. 2c, shows the degree by which each of the
variables contribute to separate the three groups. The
higher bar, the stronger discriminatory power of the
variable, i.e. the more it contributes to the group separa-
tion, and the smaller the variance bars, the greater
reliability of its contribution. The loading plot and the
VIP-plot together show that among 41 included variables,
the milk levels of EPA, DPA and DHA, i.e. ﬁsh fatty acids
of the n-3 series, had strong discriminatory power in
separating the three groups (eczema and respiratory
allergy, respiratory symptoms only and healthy) and that
high levels were associated with the healthy state. The
fatty acids 18:4 n-3, 20:1 n-7 and 20:2 n-6 also had strong
discriminating power in the PLS-DA model, but were
instead associated with the eczema and respiratory allergy
state. Further, serum EPA and AA were predictors of
healthy state, whereas high breast milk ratios of AA/EPA,
AA/DPA, AA/DHA or long-chain n-6 PUFAs/n-3 PUFAs
(n-6 LCP/n-3 LCP) were signiﬁcant contributors to the
model, but with opposite contribution – i.e. being lower in
the healthy group. Among the dietary variables, lean ﬁsh
and total intake of ﬁsh and shellﬁsh had strongest
discriminatory power in separating the groups. Those
were high in the ‘eczema and respiratory allergy’ class.
Univariate analysis
The results were conﬁrmed by univariate analysis. Women
with eczema and respiratory allergy differed clearly from
the other two groups having lower breast milk levels of
AA, EPA, DHA and DPA than either healthy women or
women with isolated respiratory allergy or both (Fig. 3a).
In contrast, women with isolated respiratory allergy did
not differ from healthy ones (Fig. 3a). Women with
eczema and respiratory allergy also had the highest ratio
of long-chain n-6 PUFAs/n-3 PUFAs (P=0.03 and 0.02
comparing with the ‘healthy’ and ‘isolated respiratory
allergy’ groups, respectively) and also higher ratio of AA/
EPA (P=0.06 and 0.07 compared with the ‘healthy’ and
‘isolated respiratory allergy’ groups, respectively) and
total n-6 fatty acids/n-3 fatty acids (P=0.09 when com-
paring healthy and eczema and respiratory allergy groups)
in their breast milk, Table 1.
The fatty acids involved in the n-6 and n-3 PUFA meta-
bolic pathways (Fig. 1) correlated positively to one another
(data not shown). Protein and lactose concentrations did not
differ between the groups of subjects (data not shown).
Fatty acids in serum phospholipids
Fatty acid composition in serum phospholipids were
assayed in blood samples. Women with eczema and
respiratory allergy had low serum levels of AA (P=0.01
and 0.02 compared ‘healthy’ and ‘isolated respiratory
allergy’ groups, respectively) and EPA (P=0.001 and
0.007, respectively), Fig. 3b. The levels of AA, EPA, DHA
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[(D=subject taking ﬁsh oil supplement, =subject taking ﬂaxseed oil supplement (rich in LNA), LCP=long-chain polyunsaturated fatty acids].
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atopic women with respiratory allergy only.
Dietary data
The weekly intake of food products expected to affect the
levels of long-chain n-3 fatty acids were assessed by food-
frequency questionnaire and converted to intake in g/wk.
As seen in Table 2, women with eczema and respiratory
allergy reported intake of as much fatty ﬁsh as healthy
women and women with isolated respiratory allergy or
even higher intake. Women with eczema and respiratory
allergy reported signiﬁcantly higher lean ﬁsh consump-
tion compared with women with isolated respiratory
allergy (11036 and 316.3, respectively, P=0.05), and
also higher total intake of ﬁsh and shellﬁsh than healthy
women (18042 and 11015, respectively, P=0.08).
Women with respiratory allergy only consumed less butter
than did healthy women (5.05.0 and 213.7, respec-
tively, P=0.03).
Discussion
In this study, we compared fatty acid composition in
breast milk and serum samples from atopic and non-
atopic women using a multivariate approach that enables
comparisons between groups of patients based on a large
set of variables. The atopic women had either respiratory
allergy only, or a combination of respiratory allergy and
eczema, while a single individual had eczema as the only
clinical manifestation of the atopic state. The groups with
both skin and respiratory symptoms were also allergic to a
larger variety of allergens, indicating more extensive
disease. Despite relatively small group sizes, differences
in fatty acid content in breast milk and serum were readily
observed. Women with eczema and respiratory allergy
were found to have a breast milk fatty acid proﬁle which
deviated signiﬁcantly from that of healthy women, but
also from women with respiratory allergy only. Most
notable was their low levels of several long-chain PUFAs
of the n-3 series. In contrast, breast milk composition
differed little between women with respiratory allergy
alone and healthy women.
Fish and shellﬁsh are the major sources of the long-
chain n-3 PUFAs EPA, DHA and DPA, and the levels of
these fatty acids in serum and breast milk are assumed to
reﬂect intake. However, women with eczema and respira-
tory allergy reported similar intake of fatty ﬁsh and higher
weekly intake of marine foods than healthy women.
Despite that, women with eczema and respiratory allergy
had lower serum levels of EPA, lower concentrations of
EPA, DHA and DPA and higher ratios of long-chain n-6
PUFAs/n-3 PUFAs and AA/EPA ratios in the milk samples.
Hence, low levels of the long-chain n-3 fatty acids in
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Fig. 2. Continued.
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Low n-3 PUFA levels in allergic women 511breast milk of women with eczema and respiratory allergy
occurred despite higher ﬁsh consumption.
Theoretically, the low levels of n-3 PUFAs in women
with eczema and respiratory allergy could depend on
dysfunction ofenzymes converting linoleic and a-linolenic
acid into long-chain n-6 and n-3 PUFAs [18, 37] (Fig. 1).
Genetic variations in FADS1 and FADS2, the D5- and D6-
desaturase which carry out this transformation, have been
shown to inﬂuence maternal plasma and breast milk fatty
acids during pregnancy and lactation [38]. It has, indeed,
been proposed that FADS gene clusters have an impact on
the risk of developing atopic disease [39].
Another explanation which is equally likely is that the
comparatively low levels of n-3 fatty acids in allergic
women are not due to low intake and/or synthesis, but to
enhanced consumption. PUFAs are raw material for
synthesis of prostaglandins and leukotrienes which may
be consumed during the allergic process. Accordingly, we
noted that a dramatic fall in serum levels of EPA, DHA and
AA concomitant with challenge in the mouse ovalbumin-
asthma model [27]. When comparing women with only
respiratory symptoms with healthy women, the only
difference found was a slightly higher ratio of total n-6
fatty acids/n-3 fatty acids in milk from atopic women.
However, consumption of long-chain n-3 PUFAs cannot
be excluded in this group either, because women with
isolated respiratory allergy had the highest intake of fatty
ﬁsh of all groups. The fact that low levels of EPA, DHA and
DPA were only seen in the groups of women with both
skin and respiratory atopy could be explained by a more
extensive disease process, involving more than one organ
and a greater number of allergens, compared with the
women with isolated respiratory allergy.
Despite what is said above, we cannot exclude that
long-chain n-3 PUFAs are protective against skin mani-
festations, but not respiratory allergy. The etiology and
pathogenesis of atopic eczema is complex involving
mainly T helper cells producing typical Th2 cytokines,
such as IL-4 in early lesions, but dominated by the Th1
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Fig. 3. Fatty acids (% of total fatty acid content) in the total lipid fraction
of breast milk (a) and serum phospholipids (b) from healthy women,
women with eczema and respiratory allergy or respiratory allergy only
(Po0.05, Po0.01).
Table 2. Dietary intake of selected fat containing food items
Intake (g/wk)
P-value
Healthy
(n=20)
Eczema1
respiratory
allergy
(n=14)
Only
respiratory
allergy
(n=7)
Fatty ﬁsh 398.6 3812 9050 NS
Lean ﬁsh 5511 11036 316.3 0.05
Shellﬁsh 16.62.6 32.116.3 16.14.1 NS
Total ﬁsh1shellﬁsh 11015 18042 13056 NS (P=0.08)
Butter 213.7 114.2 5.05.0 0.03
Margarine 113.6 184.4 176.6 NS
Vegetable oils 152.7 173.8 135.9 NS
Data was determined from food frequency questionnaires and converted
to g/wk.
MeanSEM, Student’s t-test.
Signiﬁcant difference between the indicated groups, with P value as
indicated, NS, not signiﬁcant, P=0.08
 c 2011 Blackwell Publishing Ltd, Clinical & Experimental Allergy, 41:505–515
512 S. Johansson et alcytokine IFN-g in the chronic phase [40]. Long-chain n-3
PUFAs are known to down-regulate inﬂammation. In fact,
we have observed in mouse models of Th1 and Th2
hypersensitivity that dietary ﬁsh oil reduces Th1 sensiti-
zation in a skin DTH model, but rather increased Th2 [27].
The immunomodulatory mechanisms of n-3 fatty acids
can only be speculated upon. But n-3 PUFAs affect
production of prostaglandins and related mediators, ﬂuid-
ity in membranes and gene transcription [41]. Intake of n-
3 PUFAs interfere with thrombocyte activation and coa-
gulation [42], which are intimately linkedto inﬂammation
and immunity, especially Th1-driven immune reactions
[43]. If ﬁsh oil is protective and active against the Th1-
driven phase of eczema, it may explain why women with
eczema and respiratory allergy have lower serum and
breast milk levels of n-3 fatty acids than both women
with only respiratory allergy and healthy women.
Interestingly, the original theory proposed by Dunder
[4], that high margarine consumption and low butter
consumption may predispose to allergy was supported by
the ﬁndings of our study. Thus, low butter consumption
characterized allergic women compared with healthy
ones. Whether this is the result of a wish for more ‘healthy’
life-style, or whether this diet actually aggravates allergy
cannot be deduced from our study.
Most studies investigating associations between allergy
and n-3 fatty acids in breast milk have included atopic
subjects with different types of allergic diseases in the
same group. The contradictory results reached in these
studies may, thus, not only depend on factors as season,
duration of lactation and maternal diet as proposed [44],
but might also depend on the allergic manifestation
examined. Furthermore, different groups may differ in
intake as suggested here. Hence, if respiratory allergy is
prevalent among the examined subjects, fewer differences
in fatty acid pattern may be expected to appear, than if a
high proportion of subjects with eczema are included. The
ﬁnding of low n-3 fatty acid levels in subjects with
eczema and respiratory allergy corresponds to recent
reports on low serum levels of EPA and DHA in children
with atopic dermatitis [4], the association between low
rate of eczema and early ﬁsh introduction in children’s
diet [7–9], and that breast milk given to infants who
later developed atopic eczema has low levels of n-3 fatty
acids [19].
Proportionally high levels of the fatty acids 18:4 n-3,
20:1 n-7 and 20:2 n-6 were found in the breast milk of
women with eczema and respiratory allergy. Whether this
is a secondary phenomenon or important in the pathogen-
esis of this disease cannot be deduced from our study, as
very little is known about their potential physiological
effects. 18:4 n-3, stearidonic acid, is a precursor of EPA
and is suggested to have similar biological effects and
functions as EPA [45]. It is found in seafood [46] and the
high levels in women with eczema and respiratory allergy
might relate to their high ﬁsh intake. Less is known about
the occurrence of 20:1 n-7 and 20:2 n-6 in different kinds
of food.
Our results show that low breast milk and serum levels
of long-chain n-3 fatty acids are associated with extensive
allergic disease including eczema, and that this is not due
to low ﬁsh intake. We suggest that long-chain n-3 fatty
acids are consumed during allergic inﬂammation as the
most likely explanation. However, this does not exclude
that n-3 PUFAs may be protective against immune effec-
tor functions important in eczema but not in respiratory
allergy, e.g. the strong Th1 component of the chronic
eczematous phase. Our results clearly show the impor-
tance of deﬁning the type of allergic disease involved
before giving dietary advice or testing n-3 fatty acid
supplementation for disease prevention or treatment.
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